Viewing Study NCT02642159


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-04-15 @ 3:17 AM
Study NCT ID: NCT02642159
Status: COMPLETED
Last Update Posted: 2018-05-01
First Post: 2015-12-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Sponsor: Sanofi
Organization: